Cytogel Pharma, LLC is a biotechnology research company headquartered in Darien, Connecticut, focused on reinventing pain management.
Subscribe to see Cytogel Pharma, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cytogel Pharma, LLC is a pharmaceuticals company headquartered in United States. It has raised at least $21.4M across the 8 funding rounds on record, 7 of them with a disclosed amount. Its most recent funding round raised $16M in December 2025. Xcout tracks 13 named people at Cytogel Pharma, LLC, including C. Dean Maglaris (Chief Executive Officer and Manager).
7 more named people on record for Cytogel Pharma, LLC, with roles, board committees and tenure — see the full roster →
At least $21.4M raised across the 8 rounds on record (7 with a disclosed amount). The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $16M | — | |
| Series B | Undisclosed | — | |
| SEC Form D filing | $1.8M | — | |
| SEC Form D filing | $50,000 | — | |
| SEC Form D filing | $675,355 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Cytogel Pharma, LLC's closest competitors — see the full list of competitors and alternatives →
Okogen, Inc. is a biotechnology research company headquartered in Plano, Texas, specializing in innovative eyecare solutions.
Pacira BioSciences, Inc. is a pharmaceutical manufacturing company headquartered in Parsippany, New Jersey, with operations in locations such as Brisbane, California. The company is dedicated to transforming pain management by delivering innovative, non-opioid therapies.
Mirata Pharmaceuticals, LLC develops non-addictive pain-relieving drugs as alternatives to prescription opioids. The company serves patients and physicians by creating medications that offer the analgesic benefits of opioids without their severe side effects and addictive properties.
Novilla Pharmaceuticals is a biotechnology company headquartered in Cambridge, Massachusetts, developing a novel class of localized medicines designed by AI to treat pain. The firm focuses on targeted therapeutics that function only where needed within the body. It operates as a privately held startup with a small scientific team.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.